The Congressional Academic Medicine Caucus and the Association of American Medical Colleges today sponsored a Capitol Hill briefing to highlight the urgent nationwide need for more physicians to treat substance use disorders. In calling for passage of the AHA-supported Opioid Workforce Act (H.R. 3414/S.2892), the briefing featured remarks from Reps. Brad Schneider, D-Ill., and Susan Brooks, R-Ind., the bill’s lead House sponsors, and Rep. Phil Roe (R-TN), a member of the Energy and Commerce Committee. Panelists included Bradley Allen, M.D., of the Indiana University School of Medicine; Scott Teitelbaum, M.D., of the American Society of Addiction Medicine; and Barbara Allen, executive director of James’ Place, a Maryland-based advocacy group that promotes greater access to care. 

Headline
The White House today released its national policy framework on artificial intelligence. The framework includes several recommendations for Congress…
Headline
The cigarette smoking rate among U.S. adults dropped to 9.9% in 2024, the lowest level ever recorded, according to a report by the New England Journal of…
Headline
A study published by BMJ found that glucagon-like peptide-1 (GLP-1) drugs could help reduce the risk of various substance use disorders, including for alcohol…
Headline
House lawmakers March 17 introduced the Physicians and the Healthcare Workforce Act, a bipartisan bill that would exempt foreign-trained health care workers…
Headline
An encore episode of the AHA’s Advancing Health podcast features Duke University’s Anna Tharakan, lead project manager on Closing the Gap on…
Headline
The AHA will host a webinar March 19 at 1 p.m. ET that will explore how leaders are improving retention, physician well-being and coverage…